Why Scientific Results Need Careful Interpretation
You may have seen headlines claiming that a particular food reduces disease risk by 50%, a supplement slows aging or a new treatment improves longevity.
But what do these findings really mean?
A scientific result can be interesting without being conclusive. It may also be statistically significant without making an important difference to someone’s health.
Understanding a few basic principles can help us distinguish promising findings from reliable evidence.
Association Does Not Mean Causation
Imagine a study finds that people who drink more coffee tend to live longer.
Does this prove that coffee extends lifespan?
Not necessarily.
An association means that two things are related. It does not automatically mean that one causes the other.
People who drink coffee may differ in many other ways, including their lifestyle and overall health.
To establish whether an intervention actually causes a benefit, researchers need stronger evidence, often from carefully designed clinical trials.
What Does Statistically Significant Mean?
Researchers use statistical methods to assess whether an observed difference could reasonably be explained by random variation.
A result described as statistically significant has met a predefined statistical threshold.
This means the observed result would be relatively unlikely under the statistical assumption being tested.
However, statistical significance does not tell us whether the difference is large, important or beneficial to health.
For example, a treatment might produce a statistically significant improvement in a laboratory measurement without noticeably improving how people feel or function.
Statistically significant does not necessarily mean clinically important.
A 50% Risk Reduction: What Does That Really Mean?
Imagine a study reports that a treatment reduces the risk of a disease by 50%.
That sounds impressive.
But if the original risk was 2%, reducing it to 1% means that one fewer person in every 100 would develop the disease.
If the original risk was 20%, reducing it to 10% means that ten fewer people in every 100 would develop it.
Both represent a 50% relative reduction, but the practical difference is substantial.
This is why it is useful to know the absolute risk, not just the percentage highlighted in a headline.
A Better Biomarker Is Not Always Better Health
Longevity research frequently investigates biomarkers—measurements such as cholesterol, inflammation or biological-age estimates.
These can provide valuable information about biological processes.
However, an improvement in a biomarker does not automatically mean that a person will live longer, avoid disease or remain healthier.
Some biomarkers are well-established indicators of clinical risk, while others are still being investigated.
The important question is whether a change in the measurement reliably predicts or produces a meaningful health benefit.
Why One Study Is Rarely Enough
A single study can produce an encouraging result.
But findings may differ when researchers study more people, use different methods or follow participants for longer.
Confidence increases when results are confirmed by independent research and supported by well-designed studies.
This is particularly important for new longevity treatments, where early findings may attract attention before meaningful benefits in humans have been demonstrated.
Three Questions Worth Asking
When you encounter a scientific claim about longevity, consider three simple questions:
- Was the finding demonstrated in humans? Results from laboratory experiments or animal studies may not apply directly to people.
- Was the benefit meaningful? A statistically significant change in a measurement is not necessarily an improvement in health.
- Has the result been confirmed? Findings supported by several reliable studies are generally more convincing than a single preliminary report.
These questions will not answer everything, but they provide a useful starting point.
Based on Research
Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane, 2024. https://www.cochrane.org/handbook
Wasserstein RL, Lazar NA. The ASA Statement on p-Values: Context, Process, and Purpose. The American Statistician, 2016. https://doi.org/10.1080/00031305.2016.1154108
